Comgest Growth Europe USD I H AccRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.7 | 36.1 | -8.2 | 18.6 | 13.6 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 24/04/2024 | USD 66.93 | |
Day Change | -0.37% | |
Morningstar Category™ | Other Equity | |
ISIN | IE00BYYLPD44 | |
Fund Size (Mil) 24/04/2024 | EUR 6353.65 | |
Share Class Size (Mil) 24/04/2024 | USD 22.60 | |
Max Initial Charge | - | |
Ongoing Charge 20/02/2023 | 1.05% |
Investment Objective: Comgest Growth Europe USD I H Acc |
The investment objective of the Fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 01/11/2009 | ||
Pierre Lamelin 28/02/2022 | ||
Click here to see others | ||
Inception Date 23/01/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe USD I H Acc | 31/12/2023 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 7.76 |
ASML Holding NV | Technology | 7.71 |
Essilorluxottica | Healthcare | 4.66 |
Accenture PLC Class A | Technology | 4.62 |
Linde PLC | Basic Materials | 4.10 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe USD I H Acc |